| Assessment Status | Rapid review complete |
| HTA ID | 20013 |
| Drug | Estradiol |
| Brand | Oestrogel® Pump Gel |
| Indication | For: Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women; Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. |
| Assessment Process | |
| Rapid review commissioned | 09/03/2020 |
| Rapid review completed | 09/04/2020 |
| Rapid review outcome | A full HTA is not recommended. The NCPE recommends that Oestrogel® pump be considered for reimbursement*. |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013
The HSE has approved reimbursement; August 2020.
